Bradley Foster & Sargent Inc. CT cut its stake in Silicon Laboratories (NASDAQ:SLAB) by 20.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,270 shares of the semiconductor company’s stock after selling 2,355 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Silicon Laboratories were worth $851,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in the company. Russell Investments Group Ltd. grew its stake in Silicon Laboratories by 453.6% during the 1st quarter. Russell Investments Group Ltd. now owns 14,946 shares of the semiconductor company’s stock worth $1,344,000 after buying an additional 12,246 shares during the last quarter. LPL Financial LLC purchased a new position in Silicon Laboratories during the 1st quarter worth $269,000. Legal & General Group Plc grew its stake in Silicon Laboratories by 13.0% during the 1st quarter. Legal & General Group Plc now owns 43,940 shares of the semiconductor company’s stock worth $3,950,000 after buying an additional 5,038 shares during the last quarter. Principal Financial Group Inc. grew its stake in Silicon Laboratories by 3.9% during the 1st quarter. Principal Financial Group Inc. now owns 202,945 shares of the semiconductor company’s stock worth $18,245,000 after buying an additional 7,596 shares during the last quarter. Finally, Cohen Klingenstein LLC purchased a new position in Silicon Laboratories during the 2nd quarter worth $1,188,000. Institutional investors and hedge funds own 91.34% of the company’s stock.
In other Silicon Laboratories news, Director William G. Bock sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 15th. The stock was sold at an average price of $94.50, for a total transaction of $94,500.00. Following the completion of the sale, the director now directly owns 40,751 shares in the company, valued at approximately $3,850,969.50. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Alessandro Piovaccari sold 1,404 shares of the business’s stock in a transaction that occurred on Monday, October 15th. The stock was sold at an average price of $80.72, for a total value of $113,330.88. Following the sale, the senior vice president now owns 28,265 shares of the company’s stock, valued at $2,281,550.80. The disclosure for this sale can be found here. Insiders sold a total of 10,916 shares of company stock valued at $1,015,797 in the last ninety days. 1.96% of the stock is currently owned by insiders.
Shares of SLAB opened at $86.04 on Friday. The stock has a market cap of $3.46 billion, a price-to-earnings ratio of 36.61, a PEG ratio of 1.93 and a beta of 1.50. The company has a quick ratio of 4.91, a current ratio of 5.44 and a debt-to-equity ratio of 0.34. Silicon Laboratories has a one year low of $75.89 and a one year high of $110.70.
Silicon Laboratories (NASDAQ:SLAB) last released its quarterly earnings results on Wednesday, October 24th. The semiconductor company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.98 by $0.03. The company had revenue of $230.20 million during the quarter, compared to analysts’ expectations of $227.36 million. Silicon Laboratories had a return on equity of 12.48% and a net margin of 7.45%. Silicon Laboratories’s quarterly revenue was up 15.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.90 EPS. As a group, equities research analysts expect that Silicon Laboratories will post 2.77 earnings per share for the current year.
Several research analysts recently weighed in on SLAB shares. BidaskClub upgraded Silicon Laboratories from a “hold” rating to a “buy” rating in a research note on Tuesday, July 10th. B. Riley boosted their target price on Silicon Laboratories to $123.00 and gave the stock a “buy” rating in a research note on Wednesday, July 25th. Loop Capital dropped their target price on Silicon Laboratories to $110.00 and set a “hold” rating on the stock in a research note on Thursday, July 26th. Zacks Investment Research upgraded Silicon Laboratories from a “hold” rating to a “buy” rating and set a $107.00 target price on the stock in a research note on Tuesday, July 31st. Finally, ValuEngine downgraded Silicon Laboratories from a “buy” rating to a “hold” rating in a research note on Thursday, September 27th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and seven have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $105.27.
Silicon Laboratories Profile
Silicon Laboratories Inc, a fabless semiconductor company, designs, develops, and markets mixed-signal integrated circuits (ICs) in the United States, China, and internationally. The company offers Internet of things products, such as 8-bit mixed-signal, 32-bit wireless, and ultra-low-power 32-bit microcontrollers; wireless connectivity devices, including multiprotocol wireless Gecko system-on-chip devices; real-time operating systems; sensor products comprising optical, relative humidity/temperature, and hall effect magnetic sensors.
See Also: Ex-Dividend
Want to see what other hedge funds are holding SLAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Silicon Laboratories (NASDAQ:SLAB).
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.